ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS
    4.
    发明公开
    ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS 审中-公开
    测定FÜRINFLUENZAVIRUS-HÄMAGGLUTININE

    公开(公告)号:EP3023790A1

    公开(公告)日:2016-05-25

    申请号:EP15198256.8

    申请日:2012-12-12

    申请人: Novartis AG

    IPC分类号: G01N33/569

    摘要: The invention quantifies HA using a process which comprises two key steps: HA is captured using a lectin, such as snowdrop lectin; and captured HA is quantified using an immunoassay. This assay can conveniently be performed in an ELISA format. The process is specific, is robust in the face of contaminants, and is more rapid and more sensitive than the standard SRID assay.

    摘要翻译: 本发明使用包括两个关键步骤的方法量化HA:使用凝集素如雪花凝集素捕获HA; 并使用免疫分析来定量捕获的HA。 该测定可以方便地以ELISA形式进行。 该过程是具体的,在污染物的面前是稳健的,并且比标准的SRID测定更快速和更灵敏。

    IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION
    7.
    发明公开
    IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION 审中-公开
    免责声明FÜRDIREKTE扩展UND REIFUNG

    公开(公告)号:EP2355841A1

    公开(公告)日:2011-08-17

    申请号:EP09759772.8

    申请日:2009-10-21

    申请人: Novartis AG

    发明人: DORMITZER, Philip

    IPC分类号: A61K39/00 C07K16/00

    摘要: A first antigen is administered to a subject to select progenitor B cells that are suitable for subsequent production of a desirable affinity-matured antibody, and then a second antigen is administered to stimulate the expansion of B cells that produce that affinity-matured antibody. An immunization protocol is used in which two different antigens are administered (usually in series, but in some embodiment simultaneously), where the first antigen elicits an efficient germline antibody response and the second antigen elicits an efficient and desired affinity-matured antibody response.

    摘要翻译: 向受试者施用第一抗原以选择适合于随后产生期望的亲和力成熟抗体的祖细胞B细胞,然后施用第二抗原以刺激产生该亲和力成熟抗体的B细胞的扩增。 使用免疫方案,其中两种不同的抗原(通常串联,但在一些实施方案中同时进行),其中第一抗原引发有效的种系抗体应答,第二抗原引发有效和期望的亲和力成熟的抗体应答。

    NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS
    8.
    发明公开
    NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS 审中-公开
    免疫调节剂ZUSAMMENSETZUNGEN AUS NOROVIRUS UND VERFAHREN

    公开(公告)号:EP3153578A1

    公开(公告)日:2017-04-12

    申请号:EP16199523.8

    申请日:2011-07-05

    申请人: NOVARTIS AG

    IPC分类号: C12N7/04

    摘要: The invention relates to chimeric norovirus VP1 proteins containing the S-domain of VP1 of a first norovirus strain and a P-domain that contains at least a portion of the P-domain of VP1 of a second norovirus strain. The invention also relates to nucleic acids that encode the chimeric VP1 proteins, virus-like particles that contain a chimeric norovirus VP1 protein, and to immunogenic compositions.

    摘要翻译: 本发明涉及含有第一诺罗病毒株的VP1的S-结构域和含有第二诺如病毒株的VP1的至少一部分的P结构域的嵌合诺如病毒VP1蛋白。 本发明还涉及编码嵌合VP1蛋白的核酸,含有嵌合诺如病毒VP1蛋白的病毒样颗粒和免疫原性组合物。